Skip to content
value.today

NexEos Diagnostics, Inc.

🇺🇸 Wayne, Pennsylvania, USAHealth CareFounded 2019
Total raised
$26 M
5 rounds on record
Latest round
$3 M
Feb 2026
First round on record
Jul 2019
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of NexEos Diagnostics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2026$3 MNo. 5$2 to $10 million

NexEos Diagnostics, Inc.: Raise no. 5, Feb 2026

Investors in this round

19 investors had bought by the notice of Feb 17, 2026: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Stephen Tullman · Executive Officer, Director
  • Theresa Mansi · Executive Officer
  • Christopher Molineaux · Director
  • Dennis Langer · Director
  • Jeff Himawan · Director
  • Louis Manzi · Director
  • Nicholas Siciliano · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen Tullman, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 17, 2026. Read the notice at the SEC.

equitySEC
May 2024$5 MNo. 4$2 to $10 million

NexEos Diagnostics, Inc.: Raise no. 4, May 2024

Investors in this round

22 investors had bought by the notice of Jun 6, 2024: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Stephen Tullman · Executive Officer, Director
  • Christopher Molineaux · Director
  • Dennis Langer · Director
  • Jeff Himawan · Director
  • Louis Manzi · Director
  • Nicholas Siciliano · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen Tullman, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 6, 2024. Read the notice at the SEC.

equitySEC
Feb 2023$5 MNo. 3$2 to $10 million

NexEos Diagnostics, Inc.: Raise no. 3, Feb 2023

Investors in this round

19 investors had bought by the notice of Feb 15, 2023: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$300,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Stephen Tullman · Executive Officer, Director
  • Christopher Molineaux · Director
  • Dennis Langer · Director
  • Jeff Himawan · Director
  • Louis Manzi · Director
  • Nicholas Siciliano · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen Tullman, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 15, 2023. Read the notice at the SEC.

equitySEC
Oct 2021$10 MNo. 2$2 to $10 million

NexEos Diagnostics, Inc.: Raise no. 2, Oct 2021

Investors in this round

21 investors had bought by the notice of Oct 12, 2021: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
$20,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$300,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Theresa Mansi · Executive Officer, Director
  • Christopher Molineaux · Director
  • Dennis Langer · Director
  • Jeffrey Himawan · Director
  • Louis Manzi · Director
  • Nicholas Sicilano · Director
  • Stephen Tullman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The foregoing amount includes $4,286,640 in the form of the cashless conversion of outstanding warrants.”
  • On the use of proceeds: “Approximate amount expected to be used in the next 12 months in connection with the remuneration of executive officers.”

Signed by Theresa Mansi, Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 12, 2021. Read the notice at the SEC.

equitySEC
Jul 2019$3 MNo. 1$2 to $10 million

NexEos Diagnostics, Inc.: Raise no. 1, Jul 2019

Investors in this round

4 investors had bought by the notice of Jul 30, 2019: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $6 M offered; $3 M still to sell
Smallest investment taken
$20,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$400,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Stephen Tullman · Executive Officer, Director
  • Theresa Mansi · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Theresa Mansi, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 30, 2019. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • NexEos Diagnostics, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2026).

    SEC Form D · Feb 2026

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Feb 2026

That is all the official record says: NexEos Diagnostics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of NexEos Diagnostics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 22 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by NexEos Diagnostics, Inc.
NameRoleNamed in
Stephen TullmanExecutive officerFeb 2026
Theresa MansiExecutive officerFeb 2026
Christopher MolineauxDirectorFeb 2026
Dennis LangerDirectorFeb 2026
Jeff HimawanDirectorFeb 2026
Louis ManziDirectorFeb 2026
Nicholas SicilianoDirectorFeb 2026
Stephen TullmanDirectorFeb 2026
Jeffrey HimawanDirectorOct 2021
Nicholas SicilanoDirectorOct 2021
Theresa MansiDirectorOct 2021